Latest Regulatory Milestones News

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Victory Metals has secured critical U.S. federal government approval, enabling direct engagement with the Department of Defence and access to substantial funding to advance its heavy rare earths project in Western Australia.

Tyranna Resources has agreed to acquire a 70% interest in the Maongo Copper-Gold Project in Angola, marking a strategic expansion into demand-driven metals with promising historical mining activity and strong infrastructure access.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Coda Minerals has submitted the Draft Scoping Report for its Elizabeth Creek Copper-Cobalt Project, marking a pivotal step in securing mining lease approvals in South Australia. This milestone reduces regulatory uncertainty and sets a clear path toward project development.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

Siren Gold reveals promising expansion and development prospects at its Sams Creek Project in New Zealand, with recent drilling uncovering new mineralised zones and a mining permit decision expected by year-end.

Verity Resources has appointed Dr Rick Gordon and Xirlatem Pty Ltd as strategic advisors to accelerate resource upgrades and expansion at its Monument Gold Project in Western Australia.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

Medallion Metals reports standout gold and copper assays from Harbour View infill drilling, reinforcing resource confidence ahead of a July update and advancing its strategic Forrestania acquisition.